ELECTROTHERAPY Devices Market

ELECTROTHERAPY Devices Market

Global Electrotherapy Device Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

Electrotherapy (or electromagnetic therapy) is the use of electrical energy as a medical treatment. The ‘electrically induced heat,’ as so-called diathermy, is commonly used for muscle relaxation. It is a method of heating deep tissue electromagnetically or ultrasonically for therapeutic purposes in medicine. Electrotherapy can also apply to a variety of other treatments including the use of electrical devices to stimulate deep brain tissue in neurological disease. Electrotherapy has also been applied specifically to the use of electric current to speed wound healing.

Electrotherapy is always safe and effective to use and people do not experience any side effects, as these are non-invasive methods for relieving pain. These electrotherapy devices work by delivering small electrical impulses via electrodes on skin. These mild impulses stimulate the body to produce natural pain relievers called endorphins. A drug-free, non-toxic and natural method, electrotherapy is an awesome pain relieving method for anyone who wants to get better without painkillers.

Market Dynamics: Drivers

Increasing the technological advancements of the products

Continuous advancements in technology, including innovations in device design, materials, and software, contribute to the growth of the electrotherapy device market. Newer and more efficient devices with enhanced features are being developed, providing better patient outcomes and user experiences. For instance, in February 2023, Northwestern University researchers had developed a first-of-its-kind small, flexible, stretchable bandage that accelerates healing by delivering electrotherapy directly to the wound site.

The bandage also actively monitors the healing process and then harmlessly dissolves — electrodes and all — into the body after it is no longer needed. The new device could provide a powerful tool for patients with diabetes, whose ulcers can lead to various complications, including amputated limbs or even death. Additionally, integration with digital technology has resulted in smart electrotherapy devices that can be connected to smartphones or other devices.

This connectivity allows for remote monitoring, data collection, and even adjustments to treatment parameters, enhancing patient care. These technological advancements contribute to the overall effectiveness, accessibility, and patient acceptance of electrotherapy devices, making them valuable tools in the management of various medical conditions. Continued research and innovation in this field are likely to lead to further improvements and the development of more advanced electrotherapy solutions.

Market Dynamics: Restraints

Strict regulations impose limitations on the electrotherapy devices

Regulatory agencies set stringent quality and manufacturing standards to ensure the safety and reliability of medical devices. Compliance with these standards can be resource-intensive for manufacturers, requiring investments in quality control systems, testing facilities, and adherence to Good Manufacturing Practices (GMP). Small manufacturers may find it challenging to meet these requirements.

For instance, in March 2020, the U.S. Food and Drug Administration published a final rule to ban electrical stimulation devices (ESDs) used for self-injurious or aggressive behavior because they present an unreasonable and substantial risk of illness or injury that cannot be corrected or eliminated through new or updated device labeling. The act of banning a device is rare and the circumstances under which the agency can take this action is stringent, but the FDA has the authority to take this action when necessary to protect the health of the public. Thus above factors decline the market growth.

For more details on this report– Request for Sample

Segment Analysis

The global electrotherapy device market is segmented based on type, application, end user, and region.

The TENS segment from the type segment accounted for approximately 39.7% of electrotherapy device type share

The global rise in chronic pain conditions, including musculoskeletal disorders, neuropathic pain, and arthritis, has contributed to the demand for non-pharmacological pain management solutions. TENS therapy, being a non-invasive and drug-free option, is gaining popularity, leading to more product launches. For instance, in September 2022, UltrcareCare Pro introduced TENS 2.0, a Smart - Wearable, Wireless and Pocket-sized Pain Management Device for joint, muscular and everyday pain featuring a modern design that is truly wireless with the size of a smartwatch.

TENS 2.0 gives a natural, pulsating & fast relief to people suffering from muscle soreness, arthritis, period pain, pelvic pain caused by endometriosis, knee pain, sports injuries, or any type of joint & muscular pain in the body. Additionally, in January 2022, TensCare launched its new-to-market products which offer the latest in transcutaneous electrical nerve stimulation (TENS) widely used for drug-free pain relief in the long-term treatment of chronic pain conditions such as diabetic neuropathy, back ache, sciatica, osteo-arthritis and the relief of the acute pain of childbirth. Along this will be their range of electro therapy devices, which provide improvement in muscle toning to cure bladder weakness and all types of incontinence. Thus above factors helps to accelerates the segment growth.

Geographical Analysis

North America accounted for approximately 39.4% of the market share in 2022

North America region is one of the major contributors to the market, due to the rise in sports injuries and increasing clinical trials in the region. The incidence of spinal injuries, sport-related injuries, and others, is increasing among the population. This is anticipated to fuel the demand for electrotherapy products, boosting the region growth. For instance, in the United States, there are approximately 17,000 new cases of SCI each year, and roughly 282,000 persons are estimated to be living with SCI. Males represent the majority of patients with SCI related to a sports injury.

The age group with the highest risk of SCI is from 16 to 30 years of age. Additionally, as per the source above, the electrotherapy technique is currently a significant treatment strategy that helps individuals with SCIs regain their motor function. Thus, with an increasing incidence of SCIs and nervous disease globally, the demand for electrotherapy is increasing in the North America. Furthermore, the rise of product launches and business expansion alos accelerates the market growth in the region.

For instance, on March 14, 2023, Medical equipment manufacturer Zynex launched NexWave, their pain management electrotherapy device obtainable with a prescription. By sending an electric signal to the brain from the central nervous system, pain is immediately masked and no longer sensed. Thus, above factors help to boost the region growth.

Market Segmentation

By Type
• Transcutaneous Electrical Nerve Stimulation (TENS)
• Interferential Current Therapy (IFT)
• Electrical Muscle Stimulation (EMS)
• Shockwave Therapy
• Ultrasound Therapy

By Application
• Pain Relief
• Labor Pain Management
• Anxiety and Insomnia Management
• Veterinary Pain-Management
• Aesthetic, Face lifting & Toning
• Sports Medicine

By End User
• Hospitals and Clinics
• Rehabilitation Centers

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Covid-19 Analysis

The COVID-19 pandemic has had catastrophic effects on physical health and mortality with over 670 million confirmed cases and 6.8 million deaths worldwide as of March 3, 2023. The consequences of the pandemic on mental health have also been devastating with increases or exacerbations seen in disorders such as depression, anxiety and post-traumatic stress disorder (PTSD).

Depending on the specific application of electrotherapy devices, there may have been an increased demand for certain types of devices. For example, devices used in rehabilitation and physical therapy settings may have seen increased usage due to the rehabilitation needs of COVID-19 survivors. The pandemic has accelerated the adoption of telehealth and remote monitoring solutions.

Electrotherapy devices with capabilities for remote monitoring or home use may have experienced increased interest or demand as healthcare providers sought alternative ways to deliver care. Regulatory processes for medical devices may have been affected by the pandemic. Delays in approvals or changes in regulatory requirements could impact the introduction of new electrotherapy devices to the market.

Competitive Landscape

The major global players in the market include DJO, LLC, Zynex Medical, Johari Digital, Omron Healthcare, BTL Industries, Eme srl, NeuroMetrix, Inc., Astar, Fisioline, gbo Medizintechnik AG among others.

Why Purchase the Report?
• To visualize the global electrotherapy device market segmentation based on type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of electrotherapy device market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global electrotherapy device market report would provide approximately 64 tables, 61 figures and 186pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies